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There is considerable confusion concerning the relationship of streptococcal 
fibrinolysin to the pathogenesis of disease.  Thus Madison  (1)  reported  that 
94 per cent of beta hemolytic streptococci isolated from patients with severe 
infections,  such  as  pneumonia,  septicemia,  empyema,  and  meningitis,  were 
fibrinolytic, whereas only  17 per cent of 123  strains isolated from superficial 
human  tissues lysed fibrin clots.  Dack,  Woolpert,  and  Hoyne  (2)  observed 
that  strains  of streptococci  isolated  from complicated  cases  of scarlet  fever 
were more actively fibrinolytic than those from uncomplicated cases.  Tillett 
(3) found 154 of 157 streptococci from various infections to be actively fibrino- 
lytic. 
During  the  course  of  investigations  of  streptococcal  fibrinolysis  it  was 
observed that there was a marked individual variation in the capacity of strains 
of streptococci to produce  fibrinolysin.  In contrast was the observation that 
strains  of  streptococci  isolated  during  a  food-borne  epidemic  of  exudative 
tonsillitis  exhibited a  uniform,  fibrinolytic ability (4).  These data seemed to 
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indicate that the amount of fibrinolysin produced was a characteristic property 
of  this  epidemic  strain,  and  suggested  that  the  fibrinolytic capacity  might 
therefore be a peculiar property of the individual strain of streptococcus. 
Before studying the relationship of streptococcal  fibrinolysin to the disease 
state,  it was first necessary to devise a  more  quantitative test for measuring 
fibrinolysin.  The  present  investigation  describes  the  technique which  was 
developed and reports  the results obtained in a  study of various groups and 
types of streptococci isolated in different sections of the country, from patients 
with  respiratory infections and  from healthy carriers.  In  addition,  the  re- 
lationship of the fibrinolytic  capacity of the beta hemolytic streptococcus to the 
ability of  the  homologous  organism  to  stimulate  antibody formation  was 
investigated. 
Materials  and  Methods 
Source  of Beta  Hemolytic  Streptococci.--All  beta hemolytic  streptococci,  except  where 
noted in the text, were isolated from pharyngeal cultures of well soldiers and patients with 
respiratory disease stationed at Fort Bragg, North Carolina.  The technique of swabbing the 
throat and the inoculation of the blood-agar plates wilt be described elsewhere (5).  After 
incubation  at 37°C. for 18 to 24 hours, the culture plates were examined for colonies exhibiting 
beta hemolysis.  A single colony was isolated and subcultured on a second blood-agar plate. 
When the identity  of the organism had been confirmed, an entire blood-agar plate was streaked 
and incubated for 18 to 24 hours.  This latter plate was stored in the ice box at 4°C. and was 
used as a source of organisms for grouping, typing, and tests for fibrinolysln production. 
These procedures were usually completed within 1 month after the original isolation. 
Streptococcal Grouping  and  Typing.--The  strains of  beta hemolytic  streptococci  were 
grouped according to the method of Lancefield (6) and typing~ was accomplished by means of 
the capillary tube-precipltin technique of Swift, Wilson, and Lancefield (7). 
ibrinolysin Assay: 
Fibrlnogen.--The  source of fibrinogen~  was a lyophilized preparation obtained from human 
plasma and was supplied by Dr. E. J. Cohn and Dr. S. Howard Armstrong, Jr.  A solution 
was prepared containing  0.6 gin. of fraction I in 100 ml. of buffered saline. 
Buffered Saline.--A solution of 0.01 M  phosphate in 0.85 per cent sodium chloride at pH 7.4 
was employed throughout  this study. 
Thrombin.--A commercial rabbit thrombin  was employed in a 1 to 8 dilution. 
Bacteriological Media.--Two  different media were used  to culture the beta hemolytic 
streptococcus: 
1.  Beef heart infusion broth containing  0.2 per cent dextrose. 
2.  Fibrinolysin  assay broth prepared from a single lot of tryptose  phosphate  broth (de- 
x Type -specific  rabbit serums were made available through the generosity of Dr. Homer F. 
Swift, Dr.  Rebecca  C. Lancefield, and Dr.  Chester  S.  Keefer, Director,  Commission on 
Streptococcal Infections, Army Epidemiological Board. 
The product employed was fraction I of the plasma proteins prepared by the Department 
of Physical Chemistry, Harvard Medical School, Boston, from blood collected by the Ameri- 
can Red  Cross, under a  contract recommended by the Committee  on Medical Research, 
between the Office of Scientific Research and Development and Harvard University. COMMISSION ON  ACUTE RESPIRATORY DISEASES  443 
hydrated).*  To each liter of broth was added  1.6 gm. of sodium bicarbonate in 40 ml. of 
distilled  water.  The final pH was 8.4. 
Technique of Test.--Several colonies of beta hemolytic streptococci were picked from the 
blood-agar plate and inoculated into 5 ml. of the beef heart infusion  medium containing 
several drops of mule blood. 
Following incubation in a water bath at 37°C. for 18 to 24 hours, 0.1 ml. was transferred 
to 5 ml. of beef heart infusion broth containing 0.1 ml. of mule blood.  After 8 hours' incuba- 
tion, 0.1 ml. of the supernatant was transferred to 5 ml. of the assay broth, and at the same 
time a blood-agar plate was inoculated to test for purity.  At the end of 18 hours' incubation 
in the water bath all cultures showing visual turbidity after shaking were centrifuged at 
2500 R.t,.~t. for 20 minutes.  One ml. of the supernatant broth was then removed to 4 ml. of 
buffered saline.  Serial twofold dilutions in buffered  saline were  made in a  series of nine 
chemically cleaned Wassermann tubes.  The initial dilutions ranged from 1:5 to 1:1280 and 
were contained in a total volume of 1 ml.  Automatic pipettes were then employed to add 
0.5 ml. of the fibrinogen solution, followed by 0.2 ml. of thrombin.  The racks containing the 
tubes were shaken immediately (gently).  Clotting occurred regularly within 2 to 3 minutes. 
The tubes were then incubated in a water bath at 37°C. for 60 minutes.  The titer of fibrino- 
lysin was taken as the highest dilution which lysed the clot at the end of this period.  A clot 
was considered lysed if it poured or slid readily when the tube was inverted. 
Evaluation  of Methods 
Since interest in this study was centered not only on the presence or absence 
of fibrinolysin, but also on the quantitative production of fibrinolysin, it was 
first  necessary  to  establish  the  reliability of  the  techniques  employed.  A 
definite but limited degree of variation  was found in the technique of assay. 
Early in the study two assays were made on each strain of beta hemolytic 
streptococcus  isolated.  The  second  assay was  performed  the day following 
the first and the source of the inoculum for the 8 hour culture was the 8 hour 
blood-broth  culture  which  had  been  stored  overnight  at  4°C.  Thus,  the 
difference between the two assays was that  the organisms used in the second 
determination had been passed through an additional blood-broth culture. 
The results of such duplicate tests on 213 strains of group A  beta hemolytic 
streptococci isolated from  different  subjects are presented  in Table  I.  The 
amount of fibrinolysin produced by 83  strains  (39 per cent)  was  identical in 
both assays, and in 92 additional strains  (43 per cent)  there was a  difference 
of  only  one  dilution  increment.  A  difference of  2  dilution  increments  was 
shown by 25 streptococci (12 per cent), and in only 13 strains (6 per cent) was 
the variation greater  than  2  dilutions.  Thus,  the  assays were  reproducible 
within 1 dilution increment in 82 per cent of the tests, and only 6 per cent of 
the strains exhibited considerable variation in their fibrinolytic titer. 
In the first assay there were 8 strains which failed to lyse the fibrin clot in a 
dilution of 1 : 5.  The following day, 4  of these 8 strains produced measurable 
amounts  of  fibrinolysin.  In  the  second  assay  the  total  number  of  strains 
which failed to produce lysis was 9, but 5 of these were fibrinolytic in the first 
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test.  A  total  of  71  strains  (33  per  cent)  exhibited  a  greater  fibrinolytic 
capacity in the first run as compared to the second test, and 59 (28 per cent) 
produced more fibrinolysin in the second test than in the first determination. 
These variations appear 'to be due to differences in the technique of testing, 
rather than to the number of passages in artificial media. 
The data presented  in  Table  I  demonstrate  the variations  that  may be 
expected  when  duplicate  determinations  are  made  on  successive  days  on 
cultures of the same original colony of beta  hemolytic streptococcus.  They 
TABLE I 
Duplicate Fibrinolysin Assays of 213 Group A Streptoco¢d 
Titer of fibrlnolysin 
1st Assay 
<5  5  10  20  40  80  160  320  640 
<5 
5 
10 
20 
40 
80 
160 
320 
640 
4  1  I  2  1  1 
I1  1 
2  1  113  14  9  I  5  1 
5]7  17  18  [  2 
1  1  1  2114  21  9  ]  1 
1  2  [  14  17  10 
[  1  3 
Figures refer to number of strains with the indicated titers. 
do  not  indicate,  however,  the  variations  which  may occur  when  multiple 
determinations of one strain are made on the same day. 
A study of a type 5 food-borne outbreak of streptococcal sore throat showed 
that the organisms isolated from the throat exhibited a  remarkably uniform 
ability to produce fibrinolysin (4).  The assays in that study were all performed 
in a single test.  Included in the assays were 20 strains obtained on the day the 
patients entered the hospital and 20 strains isolated from the same individuals 
6 weeks later.  These organisms had been stored in the frozen state (--70°C.) 
for a period of 6 months before testing.  The results of  these determinations 
are shown in Table II.  The amount of fibrinolysin produced by  18 of the 20 COMMISSION  ON  ACUTE  RESPIRATORY  DISEASES  445 
strains isolated at the time  of admission  to the hospital, and  20 strains iso- 
lated  6 weeks later was identical.  This  demonstrates  in  a  striking  manner 
the uniform ability of 40 strains of type 5 streptococci (all originally from the 
same source), obtained 6 weeks apart from 20 patients, to produce fibrinolysin 
when determined by tests performed on 1 day. 
In contrast with the lack of variation in the amount of fibrinolysin produced 
by 40 strains of type 5 streptococci, as determined  in a  single test,  were the 
results obtained when tests were performed on different days.  One such study 
is reported in Table III.  For a period of 175 days daily cultures of the oro- 
pharynx were taken from a  healthy volunteer who was a carrier of type  19 
beta  hemolytic  streptococcus.  During  this  period  76  type  19  strepto- 
TABLE II 
Results of Fibrinolysin Assays Performed in One Test on 40 Type 5 Streptococci Isolated from 
20 Patients 
Case NO. 
201 
202 
203 
207 
208 
213 
215 
216 
217 
225 
Fibrinolytic  capacity of 
streptococci  isolated at 
Onset  6 wks. 
tiler  Slter 
80  80 
320  80 
80  80 
80  8O 
80  80 
80  80 
80  80 
80  80 
80  80 
80  80 
Case No, 
Fibrinolytie capacity of 
streptococci isolated at 
227 
228 
234 
235 
238 
272 
273 
276 
291 
297 
Onset  6 wks. 
Hter  Nter 
80  80 
4O  8O 
8O  8O 
80  8O 
80  8O 
80  80 
80  80 
80  80 
80  80 
8O  8O 
cocci were isolated and the fibrinolytic capacity  of  each  strain  determined 
shortly  after  the  organism  was  identified.  Although  the  majority  of  the 
strains produced lysis in a  dilution of 1:20 to 1:80,  in approximately 14 per 
cent the clots were lysed only in dilutions of 1;10 or less.  These variations 
are of the same magnitude as observed in duplicate assays of the same original 
strains (Table I).  They define the limits within which quantitative interpre- 
tation may be placed on the following data.  About 3 per cent of the time a 
strain that presumably is a moderately good producer may be negative by this 
assay. 
Fibrinolytic Ability  of Different Groups of Beta Hemolytic Streptococci 
Between October, 1944,  and June,  1945, cultures were taken from approxi- 
mately 1500 soldiers with respiratory infections one or more times during the 446  STUDIES ON  STREPTOCOCCAL FIBRINOLYSIS.  V 
first 3 days of hospitalization.  In addition, several cultures of the throat were 
made  from  2500  soldiers  on  active  duty.  The  fibrinolytic capacity  of  the 
various strains of beta hemolytic streptococci isolated from these two groups of 
soldiers was determined after the organisms had been grouped and typed.  In 
all, over 2500 assays were  done on streptococci  isolated from approximately 
800 subjects. 
TABLE III 
The Prod,¢tlon of Fibrinolysin by 76 Strains  of Type 19 Streptococci Isolated Intermittently 
from a Normal Carrier during a Period of 175 Days 
No. of type 19 strains  Per cent oI type  Titer oi fibrlnolysin  isolated on different  days  19 strains isolated 
<5 
5 
10 
20 
40 
80 
160 
2 
2 
6 
22 
26 
17 
1 
3 
3 
8 
29 
34 
22 
1 
Totals  ...................  76  100 
TABLE IV 
Fibrlnolysin Tilers of 766 Strains of Beta Hemolytic Streptococci  A ccording to Lancefield Group* 
Fibrinolysin  titers  ,~  ....  Beta hemolytic 
streptococcus 
group 
A (typable) 
A (non-typable) 
B 
C 
G 
F 
<5 
13~ 
2O 
54 
22 
38 
11 
10  t  20  40  80 
6  19  22  42 
8  27  46  74 
2  1 
9  20  29  22 
12  9  15  I 17 
160  I  320  ~  1280 
20  11  2  [  1 
72  38  18  1 
20  10  2 
7  3 
Tota 
strain 
140 
312 
59 
137 
104 
14 
Median 
titer 
92 
131 
<5 
61 
20 
<5 
* Each strain was isolated from a different individual. 
:~ Number of strains with the indicated fibrinotysin titer. 
The  fibrinolytic capacity of  766  strains of  beta  hemolytic streptococci  is 
shown in Table IV  according to  the Lancefield grouping.  There  were  452 
group A  strains of which 419 or 93 per cent lysed fibrin clots in a  dilution of 
1:5  or  greater.  Similarly, 84 per cent of group C,  73 per  cent of group  G, 
21 per cent of group F, and 8 per cent of group B strains exhibited lysis in at 
least 1 : 5 dilution. 
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more fibrinolysin than the other groups.  This is indicated by the median titer 
of the various groups.  For all group A  streptococci the median titer was 117, 
for  group  C,  61,  group  G,  20,  and  groups  F  and  B  less  than  5.  It  is thus 
apparent that although groups A, C,  and  G  were  generally fibrinolytic there 
was  a  considerable  quantitative  difference  in  their  ability  to  produce  this 
substance.  It is also to be noted that a few strains of groups B  and F  strepto- 
cocci were found to cause lysis of the fibrin clot. 
Fibrinolysin Production by Various Types oJ Group A  Streptococci 
Of  the 452  group  A  strains,  140  were  typed and  the remainder were non- 
typable with the sera employed.*  The median titer of the non-typable group 
A  streptococci was  somewhat  greater  than  the  titer  of  the  typable  strains 
(Table  IV).  The  fibrinolysin production  of  the  typed  strains  is  shown  in 
Table V  (Fort Bragg 2).  Included also in this table are the results of tests on 
other typed group  A  organisms obtained from various sources.  Each  set of 
strains of a  given type are presented separately since they not only were ob- 
tained  from  various parts 'of  the  country,  but  the  organisms  were  handled 
differently following isolation. 
Fort Bragg I strains were isolated in the late winter and spring of 1944 from patients with 
respiratory infections and from normal soldiers.  These strains had been either lyophilized  or 
frozen in milk and stored at -- ?0°C. for a period of 6 months before testing.  Each organism, 
therefore, had probably been passed through at least ten cultures before the fibrinolyfic 
capacity was tested. 
Fort Bragg 2 strains  were isolated  in 1944-1945 and had undergone a minimum of cultivation 
in the laboratory before testing.  The method of handling these organisms was described 
above. 
Fort Bragg 3 organisms were isolated during the month of March, 1946, from patients with 
scarlet fever and the fibrinolytic  capacity  was tested within 6 weeks after isolation.  The type 
30 organisms were responsible for a small outbreak of scarlet fever during this period. 
Fort Lewis.  These organisms were isolated in the winter and spring of 1945 at Fort Lewis, 
Washington, and were supplied by Dr. Morton Hamburger, Jr.  About half of the strains 
were obtained from hospitalized soldiers, the remainder came from carriers.  Most of the 
streptococcal  infections occurred sporadically, although some of the strMI~-of the same type 
may have come from a parent source. 
The number of passages that these organisms had undergone prior to testing is not known 
but they had been stored on blood-agar slants for at least 4 to 6 months. 
New York strains were received in the ]yophilized  state from Dr. Sidney Rothbard.  The 
isolations had been made in 1941-1944 from patients with scarlet fever, rheumatic fever, or 
pharyngitis. 
Boston.  The organisms supplied by Dr. T. Duckett Jones were isolated from patients in 
the House of the Good Samaritan during the preceding 2 years, and had been stored in the 
lyophilized state. 
* The following typing sera were employed: types 1, 2, 3, 4, 5, 6, 8, 9, 11, 12, 13, 14, 15, 17, 
18, 19, 22, 23, 24, 26, 28, 29, 30, 31, 33, 34, 36, 37, 38, 39, 40, 41, 42, 43, 44, 46, and 47. 448  STUDIES  ON  STREPTOCOCCAL  FIBRINOLYSIS.  V 
TABLE V 
Fibrinolytic Capacity of 372* Different Strains of Group A Streptococci According to Type 
I 
Beta hemolytic  streptococcus  group A  [  Fibrinolysin t.ltem 
I 
I  I Tota  Source  Type  <5  5  10  20  40  80  160  320  640 [ Strains 
Fort Bragg 1..  1  4:  1  1  2  8 
Fort Bragg 2..  1  1  1  2  3  4  4  15 
Fort Lewis  1  1  1  1  6  3  1  13 
Totals..  1  6  2  2  9  6  7  4  36 
FortBraggl...  3  16  1  4  7  4  32 
Fort Bragg 2.  3  3  1  1  5 
Fort Bmgg 3.,  3  4  4 
Fort Lewis..  3  5  2  7 
New York.  3  9  1  10 
Totals.  3  37  1  1  1  5  9  4  58 
Fort Bragg ]  5  1  1  2  3  7 
Fort Bragg 2.  5  1  3  1  5 
New York..  5  4  2  1  7 
Boston.  5  1  1 
Texas.  5  1  1 
Totals. 
Fort Bragg 1. 
Fort Bragg 2.., 
Fort Lewis. 
Totals. 
Fort Bragg 1. 
Fort Bragg 2. 
Fort Lewis: 
Totals. 
Fort Bmgg 2. 
Fort Lewis. 
Totals. 
Fort Bragg 3. 
Fort Lewis. 
New York. 
Totals. 
5  1  3  5  7  4  1  21 
6  3  8  4  15 
6  4  4  8  16 
6  5  6  I  12 
6  4  12  22  5  I  43 
12  1  1  3  5  10 
12  5  1  1  1  2  7  3  1  21 
12  1  2  2  7  12 
12  6  1  2  1  5  12  15  1  43 
14  I  I  1  1  2  i  7 
14  2  6  4  12 
14  1  1  1  3  8  5  19 
17  4  2  6 
17,  1  1  8  3  13 
17  1  1 
17  1  I  6  10  3  20 
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TABLE V--Condud~l 
Beta hemolytic streptococcus group A  Fibrinolysln  tlters 
Source 
Fort Bragg 2 .... 
Fort Bragg 1  "l 
Fort Bragg 2... 
Fort Bragg 3 .................. 
Type  <5 
18  1 
19 
19 
19 
5  10120] 
4  1 
3 
2 
Fort Lewis 
New York .... 
Boston.• 
Atlanta  ........ 
Totals  ...... 
Fort Bragg 2 .... 
Fort Bragg 1... 
Fort Bragg 2 .... 
Fort Bragg 2... 
Fort Bragg 3 
Fort Bragg 2 
.[  19  1 
19 
•  I 19  1  1 
• 1 19 
19  1  1  6 
.I 
•  24  2  1  3 
26 
.  28 
29  1  1 
i  3o 
45  1 
! 
40  80  I  160 
I  5  6  I 
2  15  4 
5  7 
4 
3  6  1 
1 
1 
4 
20  28  S 
1  2 
2  2 
2 
1  1 
13  4 
3 
Total  320  640  strai~ 
i  18 
6  27 
15 
6 
1  1  13 
1 
3 
4 
7  1  69 
1  !  10 
2  !  6 
2  4 
4 
i  17 
I  4 
* 16 strains which were typed are omitted because less than 4 organisms were  present 
in each type. 
:~ Number of strains with the indicated fibrinolysin titer. 
Fort Bragg 1, isolated in winter 1944. 
Fort Bragg 2, isolated in winter 1944-1945. 
Fort Bragg 3, obtained fro m cases of scarlet fever in March, 1945. 
Texas.  The type 5 streptococcus was isolated by Dr. R. Pike from a patient with a sore 
throat in March, 1945, and was stored on a blood-agar slant until tested in May, 1946. 
Atlanta.  Dr. Carl T. Nelson supplied these organisms which were recently isolated from 
hospitalized  patients and had been stored on blood-agar slants. 
It is apparent from the results shown in Table V  that the distribution of the 
fibrinolytic capacities of a  series of organisms of the same type was, in general, 
similar, irrespective of the year or part of the country in which the organism 
was isolated.  Furthermore, lyophilization or the age of the culture apparently 
did not interfere markedly with the fibrinolytic capacity.  For example, the 
type 3 streptococci isolated at Fort Bragg in the winter of 1944, 1944-1945,  and 
in March, 1946, all exhibited a similar lack of fibrinolytic ability.  Strains from 
New York and Fort Lewis were essentially similar.  Two of the sets of type 3 
organisms had been lyophilized, and yet a number  were fibrinolytic, whereas 
none of 4  strains obtained in 1946 from patients with scarlet fever, and tested 
shortly after isolation, causes lysis of the fibrin clot. 450  STUDIES  ON  STREPTOCOCCAL  ~'IBRINOLYSIS.  V 
The results obtained with the Type 6 organisms were striking.  One group 
had been lyophilized in  1944  (Fort Bragg  1),  one had been recently isolated 
(Fort Bragg 2), and the final group (Fort Lewis) had been stored for 6 months 
on  blood-agar  slants.  These  organisms  all  produced  similar  quantities  of 
fibrinolysin. 
There were some instances, however, where the fibrinolytic capacities varied 
somewhat within a given type, depending on the source of the organism.  An 
example is shown in type 12 organisms, where 5 of 21 strains isolated at Fort 
Bragg in 1944-1945 failed to lyse the fibrin at a  dilution of 1:5 and only 1 of 
TABLE  VI 
Median Titers and Average  Production of Fibrinolysin According to the Type of Group A 
Streptococcus 
Type 
3 
24 
1 
18 
30 
5 
19 
6 
17 
14 
12 
Total strains 
58 
10 
36 
18 
17 
21 
69 
Median titer 
<5 
33 
38 
64 
66 
97 
99 
43  100 
20  104 
19  230 
43  283 
Titer of less 
than 5 
per cent, 
64 
20 
17 
Distribution by titer groups 
Titer of  Titer of 
5 to 39  40 to 159 
per cent  #er cent 
3  10 
40  30 
36  36 
Titer of 160 
or greater 
per cent 
22 
10 
11 
5 
14 
28 
0 
19 
10 
61 
100 
57 
70 
79 
80 
21 
14 
5 
0 
24 
19 
12 
15 
68 
65 
10 strains isolated the year before and subsequently frozen failed to lyse the 
clot.  Twelve type 12 strains from Fort Lewis were all fibrhlolytic. 
A comparison of the fibrinolytic capacities of the separate types of group A 
streptococci showed considerable differences.  This is shown in Table V and in 
summary form in Table VI where the median titer as well as the distribution 
of the fibrinolytic capacities of each series of organisms containing 10 or more 
strains of a given type is recorded.  The median titer ranged from < 5 in the 
group of type 3 streptococci to 283 for the type 12 organisms.  Types 3, 24, 
and I produced small amounts, types 18, 30, 5, 19, 6, and 17, moderate amounts, 
and types 14 and 12 large amounts of fibrinolysin. 
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various types, but also the distribution varied according to type, thus, 64, 20; 
and 17 per cent of types 3, 24, and 1 streptococci,  respectively,  failed to lyse 
the clots in a 1: 5 dilution.  In the type 12 organisms, which had a high median 
titer, 14 per cent did not exhibit fibrinolysis but the majority of the remaining 
strains exhibited titers  of over  160.  Of  the  type 3  organisms  which  were 
fibrinolytic,  two-thirds produced large  amounts of fibrinolysin.  In  contrast 
are types 24 and 1 which produced low to moderate amounts when any fibrino- 
lyric ability was exhibited. 
The striking consistency  of the fibrinolysin production by type 30 strepto- 
cocci is probably explained by the fact that they were all isolated during an 
epidemic, and the organisms were tested on one day, which, as shown above, 
tends to decrease the variation in the test.  The type 17 streptococci,  on the 
other hand, were isolated from three widely separated parts of the country and 
were  tested on different days, and yet 80 per cent of the strains produced 
fibrinolysin in titers of between 1: 40 to 1 : 80. 
Fibrinolysin Production of Streptococci Isolated from Cases and from  Carriers 
The fibrinolytic capacity of strains of streptococci  of the same type did not 
appear to vary according to whether they were isolated from normal carriers 
or from patients with infection.  For example, of the 15 type 6 strains isolated 
at Fort Bragg in the spring of 1944, 3 were obtained from patients with strepto- 
coccal infections, the remainder from carriers.  Two of the 16 strains isolated 
in 1944-1945 were from streptococcal infections, and all but 3 of the'Fort Lewis 
strains were isolated from hospitalized  patients who presumably had strepto- 
coccal pharyngitis.  Thus, strains of type 6, isolated from cases with infection 
and from carriers produced similar amounts of fibrinolysin. 
Six of the type 19 streptococci  (Fort Bragg 3) were from cultures from the 
throats of patients with scarlet fever, and most of the remainder of the strains 
isolated at this post were from oropharyngeal cultures of carriers.  In both 
instances similar quantities of fibrinolysin were produced. 
The type 3 streptococci varied in their fibrinolytic  ability, but this variation 
could not be correlated with the source of the organism.  Of the 16 strains that 
produced no fibrinolysin  (Fort Bragg 1, Table V), 11 were isolated during the 
acute phase of streptococcal  infections,  and 5 were from carriers.  Of the 16 
strains (Fort Bragg 1)  that produced fibrinolysin,  5 were from cases, and 11 
from carriers. 
The data presented in Table II are interesting in this regard, since haft of the 
type 5 strains were isolated during the acute phase of illness, and half 6 weeks 
later.  All except 2 strains produced similar amounts of fibrinolysin, demon- 
strating that the fibrinolytic capacity of organisms from convalescent carriers 
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for a period of 5 days.  Such therapy, however, did not affect the production 
of fibrinolysin. 
Relation of Fibrinolysin Production to the Ability of the Organism to Stimulate 
Antibody  Formation 
A preliminary report  (8) has demonstrated that antitibrinolysin production 
following infection is related to the fibrinolytic capacity of the infecting or- 
ganism.  These observations were extended in the present study.  Acute and 
convalescent phase serum specimens were available for antibody determination 
from approximately 90 per cent of the hospitalized subjects from whom beta 
hemolytic streptococci were  isolated.  A  patient was  considered  to  have  a 
streptococcal infection if an increase in titer of 2 dilution increments of either 
TABLE VII 
The A ntifibrinolysin Response in 56 Cases of Proved Streptococcal Infections* According to tke 
Fibrinolytic Ability of tke Infecting Strain 
I 
Fibrinolytic  capacity of the infecting strain  l Total No. cases 
I 
Titer of 5 or less  .......................  I  26 
Titer of 160 or greater  ..................  [  30 
igo. of cases with 
increase of 
an tifibrlnolysin 
6 
,22 
Per cent with 
increase of 
antitlbriuolysin 
23 
73 
* An increase in antistreptolysin or antifibrinolysin titer of at least 2  dilution increments 
was demonstrated in the convalescent serum collected from each of these patients. 
antifibrinolysin  or  antistreptolysin  was  demonstrated  in  the  convalescent 
phase serum specimen (9). 
For the present analysis, only those patients infected with organisms which 
produced fibrinolysin in a  titer of 1:5 or less and those infected with strepto- 
cocci which elaborated fibrinolysin in titers of 1:160 or greater were considered. 
As shown in Table VII, a total of 56 such patients had streptococcal infections 
caused  by  these  organisms.  Twenty-six patients  were  infected by  strains 
producing little or no fibrinolysin, and only 6 or 23 per cent exhibited an in- 
crease in antifibrinolysin during convalescence.  This is in contrast to 22, or 
73 per cent of 30 patients who were infected by streptococci elaborating large 
amounts of fibrinolysin in vitro and who showed an increase in the antifibrino- 
lysin titer of the serum following infection. 
RECAPITULATION  AND  DISCUSSION 
The studies reported in the present paper were undertaken in an attempt to 
clarify and extend the knowledge of the  relationship of streptococcal tibrino- 
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of a sufficiently quantitative method for measuring the fibrinolysin production 
of strains of beta hemolytic streptococci.  Most assays have been made by 
incorporating the organisms in plasma clots and observing the time in which 
complete  lysis  occurred.  The  rapidity  with  which  liquefaction  occurred 
provided a rough index of the amount of fibrinolysin  produced. 
Recent studies of the mechanism of streptococcal fibrinolysis have facilitated 
the development of a more quantitative test (10, 11).  It has been shown that 
fibrinolysin produced by the beta hemolytic streptococcus activates  a  sub- 
stance, lyric factor,  (12) which is normally present in human plasma.  This 
activated protease is responsible for the liquefaction of the fibrin clots.  By the 
use of a purified fibrinogen  preparation which contained an adequate and con- 
stant  amount  of lyric factor it was possible to devise a  simple method for 
testing fibrinolysin production.  In this test the concentration of fibrinolysin 
was measured by determining the smallest amounts that liquefied the standard 
fibrin clot after 60 minutes' incubation. 
By using this method, more reproducible results were obtained.  Multiple 
tests performed in an identical manner on the same day yielded highly con- 
sistent  results.  Variations  were still  observed, however, from  day  to  day, 
which presumably were related to uncontrollable differences  in the beef heart 
infusion  broth  used  t9  grow  the  streptococcus.  In  order  to  reduce  these 
variations to a minimum, a  standard assay broth was finally adopted, which 
consisted of one lot of dehydrated tryptose phosphate.  By the use of a large 
inoculum of a rapidly growing culture of the test organisms,  adequate growth 
in this broth was usually obtained.  The amount of fibrinolysin  produced in 
this medium was not maximal, but the variation  from day to  day was con- 
siderably reduced.  By testing  a  large  number  of strains  in  duplicate,  the 
limits of variation of this method were defined; and although there is need for 
further standardization of the technique, it is believed that the results of the 
present study are more quantitative  than  those which have been  reported 
previously. 
It has been observed previously (13) and also confirmed in this laboratory 
that strains of beta hemolytic streptococci occasionally lose their fibrinolytic 
ability upon  prolonged  passage  in  artificial  media.  In  the  present  study, 
however, the fibrinolytic capacity did not appear to vary with the methods of 
storage nor with a limited number of passages of the test organisms.  Thus, 
•  the fibrinolytic production of streptococci seems to be reasonably stable and, 
at least, not to vary as much as was previously thought. 
Other studies have indicated that the majority of group A streptococci are 
fibrinolytic, (14, 15) and this observation was confirmed in the present study. 
Of the  groups  C  and  G  strains,  84 and  63  per cent respectively produced 
fibrinolysin.  This  is  essentially  in  agreement  with  the  findings  of  others 454  STUDIES  ON  STREPTOCOCCAL ~'IBI~INOLYSIS.  V 
Fibrinolytic properties have not been observed in other Lancefield groups of 
beta hemolytic streptococci  (18,  19).  Five of 59  group  B  and  three of  14 
group  F  streptococci reported here produced  small amounts of fibrinolysin. 
Not only do most of group A organisms possess fibrinolytic properties, but, 
in general, they produce large amounts of the substance in comparison with the 
Lancefield groups C and G.  The median titer for group A organisms was 117, 
group C, 61, and group G, 20. 
In a preliminary study, evidence was obtained that fibrinolysin production 
was also related to  the type of group A  streptococcus  (8).  In  the present 
study,  therefore,  strains  of  the  various  types were  collected over  a  3  year 
period at Fort Bragg and also from other sections of the country.  In each 
instance the strain was isolated from a different individual.  Many of the typed 
streptococci at Fort Bragg were obtained from recruits within 1 week after 
their arrival at this army post from various induction stations situated east of 
the  Mississippi  River.  Practically all  strains  at  Fort  Bragg were  isolated 
from recruits who remained there for less than 4 months.  It would appear, 
therefore, that the majority of the streptococci within a  given type were not 
derived from an immediate common source.  This factor is of some importance, 
since, as expressed above, organisms derived from a  common source exhibit 
similar fibrinolytic properties.  To establish the relationship of the serological 
types to fibrinolysin production, therefore, a number of strains were obtained 
from multiple sources. 
Although the majority of group  A  strains of beta hemolytic streptococci 
produce moderate amounts of fibrinolysin the  data  (Table  V)  suggest that 
fibrinolysin production is related to the type of streptococcus.  Perhaps the 
most striking example was  the production of fibrinolysin by the type 6  or- 
ganisms.  Fifteen strains collected at Fort Bragg in the late winter of 1944, 
16 strains isolated during 1944-1945  at the same post, and 12 strains obtained 
from Fort Lewis, all lysed fibrin clots in a  dilution  of  from  1:20  to  1:160. 
Thirty-four of the 43 strains lysed the fibrin clots in a dilution of 1:40 or 1:80. 
Type  5  streptococci  from  North  Carolina,  New  York,  Massachusetts,  and 
Texas produced moderate amounts of fibrinolysin.  In marked contrast were 
the  results  with  the  type 3  organism.  In  this  series,  the  majority  of  the 
strains isolated over a 3 year period at Fort Bragg, and most of the organisms 
from New York and Fort Lewis, failed to  cause lysis  in  a  dilution of  1:5. 
Although a rather consistent pattern of fibrinolysin production was exhibited 
by series  of organisms from various sources  within a  given type,  it is  to be 
emphasized that some types are apparently characterized by organisms  that 
produced amounts of fibrinolysin within a narrow range, while others exhibit a 
wide range.  Thus types 6 and 17 streptococci were remarkably consistent in 
their fibrinolytic capacity. 
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ability to produce fibrinolysin.  Further studies are required, however, before 
such variations may be established as a characteristic of these types. 
By the use of median  titers,  the general  differences  between the types of 
streptococci were shown  in  a  striking  fashion.  Thus  58  type  3 organisms 
had a median titer of  <5, whereas a median titer of 283 was exhibited by 43 
type 12 organisms.  On this basis,  then,  types 1, 3,  and  24 produced small 
amounts, types 5, 6, 17, 18, 19, and 30 moderate amounts, and types 12 and 14 
large amounts (Table VI). 
These studies clarify to some extent the results reported in the past con- 
cerning the relationship of steptococcal fibrinolysis  to infection (18).  Several 
of these reports have indicated that streptococci obtained from patients with 
severe or suppurative infections were markedly fibrinolytic, whereas organisms 
isolated from mild infections produced little or no fibrinolysin.  The results 
reported with  strains  isolated from  infectious processes, however, have not 
been  consistent.  Thus,  Tillett  (3)  reports  his  observations  on  157  strains 
of beta hemolytic streptococci isolated from various diseases and found 154were 
fibrinolytic.  Madison  (1),  in  contrast,  found fibrinolytic properties in  only 
17 per cent of 123 strains from patients with a variety of infections.  It has 
been suggested that these differences may be due to absence of lytic properties 
in the strains from minor infections or they may have been caused by laboratory 
cultivation of the organism prior to the time to testing  (18). 
On the basis of the present studies, it appears that the variations described 
previously may have been due to the type of organism studied, and also to 
the  assay medium  used  to  cultivate  the  streptococci.  The majority of the 
group A  strains were isolated from healthy subjects and most of them were 
found  to  exhibit fibrinolytic properties  when  tested.  Some  of  the  type 6 
organisms  were obtained from proved  streptococcal infections,  others from 
carriers,  and  yet  they  all  produced  similar  quantities  of fibrinolysin.  Six 
of the type 19 streptococci (Fort Bragg 3) were from cultures from the throats 
of patients with scarlet fever, and most of the remainder of the strains isolated 
at this post were obtained from cultures from well soldiers.  In both instances, 
similar quantities of fibrinolysin  were produced.  These data,  though limited, 
suggest that fibrinolysin  production is not necessarily related to the disease- 
producing capacity of the organism. 
Other studies have indicated that there is a relationship between the pro- 
duction of antifibrinolysin following infection and the type of group A strep- 
tococcus causing the disease (8, 20).  Further studies established a relationship 
between the in vitro fibrinolytic capacity of the infecting  organisms and anti- 
fibrinolysin  formation  (8,  20).  The  present  investigations  confirmed  these 
findings.  Of the 26 proved streptococcal infections  caused by organisms pro- 
ducing little or no fibrinolysin  when  tested in the routine manner, 6 or 23 per 
cent  of  the  patients  exhibited  an  increase  in  fibrinolysin  antibodies  during 456  STUDIES  ON" STREPTOCOCCAL  ]~IBRINOLYSIS.  V 
convalescence.  In contrast, 73 per cent of 30 patients infected with organisms 
producing large amounts of fibrinolysin  exhibited a  specific antibody response. 
Thus, there was a distinct correlation  between the antifibrinolysin response 
in  patients  and  the  fibrinolytic capacity of  the  infecting  strains.  The  six 
cases in which a response was detected in the absence of appreciable fibrinolysin 
production of the strain  warrant  special comment.  It  seems probable that 
these strains actually produced considerable fibrinolysin in vivo which was not 
detected in the standardized  in vitro  test used in this study.  As mentioned 
previously, the culture medium used as routine was not ideal.  In exploratory 
studies of this problem, certain  strains  of type 3  organisms which failed to 
produce fibrinolysin  in  the routine  test  were retested  after  growth  in  beef 
heart infusion broth buffered with Mote's modification of the I-Iodge and Swift 
buffer (21).  Under these more ideal but less standardizable conditions, most 
of  these  organisms  were found  to  produce limited  amounts  of fibrinolysin. 
It  seems likely,  therefore,  that  many of the  variations  which  have been 
observed in the fibrinolysin  production of beta hemolytic streptococci in the 
past may be related to variations and irregularities in the tests used and in 
the media on which  the organisms are grown.  The studies reported in the 
present paper in which a  more quantitative and more reproducible test was 
employed failed to confirm many of the relations which have been reported 
previously.  There  is  still  need,  however,  for  further  standardization  and 
quantitation of the methods of determining fibrinolysin. 
SUMM&Ry 
A method for the measurement of fibrinolysin production by beta hemolytic 
streptococci is described.  The test was shown to be highly accurate in that 
repeated determinations showed only small variations.  A study of 766 strains 
of beta hemolytic streptococci isolated from normal soldiers and patients with 
respiratory disease showed that fibrinolysin was produced by Lancefield groups 
A, C, and G, and, in addition, by a few strains of groups B and F. 
Group A  streptococci produced more fibrinolysin  on the average than  the 
other groups.  The median titers were 117 for group A, 61 for group C, and 
20 for group G streptococci.  In a  study of 388 typed group A  streptococci 
from different subjects the fibrinolytic capacity of an organism was shown to 
be related  to  the  serological  type.  The  importance  of  this  observation  in 
relation to the r61e of streptococcal fibrinolysis  in infections is discussed. 
Finally,  it  was demonstrated  that  strains  of streptococci which produced 
large  amounts  of  fibrinolysin  were  capable  of  stimulating  antifibrinolysin 
formation in patients whereas strains  that produced small amounts only oc- 
casionally caused antibody formation. 
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